WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the 218th co-sponsor of H.R. 523, the “Protect Medical Innovation Act of 2013,” providing the bill enough support to pass the U.S. House of Representatives:
“This important milestone for repealing the medical device tax is another strong signal that there is overwhelming bipartisan support in Congress to put an end...
Vote Underscores Bipartisan Support for Device Tax Repeal Efforts
Washington, D.C. – The Medical Device Manufacturers Association (MDMA), Advanced Medical Technology Association (AdvaMed) and the Medical Imaging & Technology Alliance (MITA) today applauded the adoption of an amendment to the Fiscal Year 2014 Senate Budget Resolution that expresses support for repeal of the medical device tax. The amendment passed with 79 votes.
“Today’s...
WASHINGTON, DC – Highlighting the job losses and negative impact to patient care already caused by the medical device tax, leaders in the medical technology industry urged Members of Congress at a hearing today to act quickly to repeal a policy that is threatening America’s leadership position. Board members of the Medical Device Manufacturers Association (MDMA) noted that while the 2.3% device tax has only been enacted for two months, it has led to the loss of...
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement regarding the Senate Budget Committee hearing to examine the impact of federal investments on families, communities and long-term and broad-based economic growth:
“While the medical device tax has only been in effect for two months, the devastating impact of a policy...
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement in response to President Obama’s State of the Union Address:
“MDMA agrees with the President that we need to grow our economy by expanding our manufacturing base while creating more middle class jobs. The secret to accomplishing these goals is to empower innovative and entrepreneurial businesses, and the medical...
Washington, D.C. – A coalition of medical device manufacturers today applauded Members of the Senate and House of Representatives for their recent bipartisan efforts to repeal the 2.3% medical device excise tax. Today, Senators Orrin Hatch (R-UT) and Amy Klobuchar (D-MN) introduced the “Medical Device Access and Innovation Protection Act” and yesterday, Reps. Erik Paulsen (R-MN) and Ron Kind (D-WI) introduced the “Protect Medical...
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding introduction in the U.S. House of Representatives of H.R. 523, the “Protect Medical Innovation Act:”
“MDMA thanks Congressman Paulsen and Congressman Kind for their continued leadership on this crucial issue for medical innovation and patient care, and we remain fully committed to repealing the device tax. There is...
Washington, D.C. – A coalition of medical device manufacturers said that today’s first semimonthly payment of approximately $97 million to the IRS for the medical device tax is money that companies would have otherwise been available to invest in research and development (R&D) and American job growth.
“Instead of investing in new medical technologies or creating new jobs, innovators across the United States wrote a check to the IRS this month,” said...
A report released this week by the equity research department of a leading investment bank focusing on medical technology included forecasts that implementation of the Affordable Care Act would do little to cause an uptick in medical device utility.
The report specifically cited the following reasons why ACA implementation would have a “minimal” impact on the med-tech industry:
WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement regarding the fiscal cliff deal and the failure to repeal the medical device tax:
“While MDMA is disappointed that a deal was not reached to repeal the medical device tax, we are heartened by the bipartisan and growing support in both the House and Senate to end this policy. There is wide recognition that the device tax has...
